Distinct chromosomal bias of gene expression signatures in the progression of hepatocellular carcinoma

被引:50
|
作者
Midorikawa, Y
Tsutsumi, S
Nishimura, K
Kamimura, N
Kano, M
Sakamoto, H
Makuuchi, M
Aburatani, H
机构
[1] Univ Tokyo, Adv Sci & Technol Res Ctr, Genome Sci Div, Meguro Ku, Tokyo 15389004, Japan
[2] Univ Tokyo, Adv Sci & Technol Res Ctr, Intelligent Cooperat Syst Div, Tokyo 15389004, Japan
[3] Univ Tokyo, Hepato Biliary Pancreat Surg Div, Tokyo 15389004, Japan
关键词
D O I
10.1158/0008-5472.CAN-04-1275
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
To identify the chromosomal aberrations associated with the progression of liver cancer, we applied expression imbalance map analysis to gene expression data from 31 hepatocellular carcinomas and 19 noncancerous tissues. Expression imbalance map analysis, which detects mRNA expression imbalance correlated with chromosomal regions, showed that expression gains of 1q21-23 (74%), 8q13-21 (48%), 12q23-24 (41%), 17q12-21(48%), 17q25 (25%), and 20q11 (22%) and losses of 4q13 (48%), 8p12-21 (32%), 13q14 (32%), and 17p13 (29%) were significantly associated with hepatocellular carcinoma. Most regions with altered expression identified by expression imbalance map were also identified in previous reports using comparative genomic hybridization. We demonstrated chromosomal copy number gain in 1q21-23 and loss in 17p13 by genomic quantitative PCR, suggesting that gene expression profiles reflect chromosomal alterations. Furthermore, expression imbalance map analysis revealed that more poorly differentiated hepatocellular carcinoma contain more chromosomal alterations, which are accumulated in a stepwise manner in the course of hepatocellular carcinoma progression: expression imbalance of 1q, 8p, 8q, and 17p occur as early events in hepatocarcino-genesis, and 12q, 17q25 and 20q occur as later events. In particular, expression gain of 17q12-21 and loss of 4q were seen to accumulate constantly through the dedifferentiation process. Our data suggest that gene expression profiles are subject to chromosomal bias and that expression imbalance map can correlate gene expression to gene loci with high resolution and sensitivity.
引用
收藏
页码:7263 / 7270
页数:8
相关论文
共 50 条
  • [1] Gene expression signatures of stepwise progression of Hepatocellular Carcinoma
    Porukala, Manisri
    Vinod, P. K.
    PLOS ONE, 2023, 18 (12):
  • [2] Gene Signatures in the Management of Hepatocellular Carcinoma
    Hoshida, Yujin
    Moeini, Agrin
    Alsinet, Clara
    Kojima, Kensuke
    Villanueva, Augusta
    SEMINARS IN ONCOLOGY, 2012, 39 (04) : 473 - 485
  • [3] Gene signatures in hepatocellular carcinoma (HCC)
    Andrisani, Ourania M.
    Studach, Leo
    Merle, Philippe
    SEMINARS IN CANCER BIOLOGY, 2011, 21 (01) : 4 - 9
  • [4] Comprehensive meta-analysis reveals distinct gene expression signatures of MASLD progression
    Piras, Ignazio S.
    Distefano, Johanna K.
    LIFE SCIENCE ALLIANCE, 2024, 7 (06)
  • [5] The gene expression signatures of melanoma progression
    Haqq, C
    Nosrati, M
    Sudilovsky, D
    Crothers, J
    Khodabakhsh, D
    Pulliam, BL
    Federman, S
    Miller, JR
    Allen, RE
    Singer, MI
    Leong, SPL
    Ljung, BM
    Sagebiel, RW
    Kashani-Sabet, M
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (17) : 6092 - 6097
  • [6] Identification of molecular heterogeneity of hepatocellular carcinoma based on immune gene expression signatures
    Lou, Xin
    Wang, Juan-Juan
    Wei, Ya-Qing
    He, Ying-Jie
    Jiang, Zhi-Jia
    Sun, Jin-Jin
    MEDICAL ONCOLOGY, 2021, 38 (05)
  • [7] Signatures of gene expression, DNA methylation and microRNAs of hepatocellular carcinoma with vascular invasion
    Sulaiman, Siti A.
    Abu, Nadiah
    Ab-Mutalib, Nurul-Syakima
    Low, Teck Yew
    Jamal, Rahman
    FUTURE ONCOLOGY, 2019, 15 (22) : 2603 - 2617
  • [8] Identification of molecular heterogeneity of hepatocellular carcinoma based on immune gene expression signatures
    Xin Lou
    Juan-Juan Wang
    Ya-Qing Wei
    Ying-Jie He
    Zhi-Jia Jiang
    Jin-Jin Sun
    Medical Oncology, 2021, 38
  • [9] Distinct diagnostic and prognostic values of Glypicans gene expression in patients with hepatocellular carcinoma
    Jian-Yao Wang
    Xiang-Kun Wang
    Guang-Zhi Zhu
    Xin Zhou
    Jun Yao
    Xiao-Peng Ma
    Bin Wang
    Tao Peng
    BMC Cancer, 21
  • [10] Distinct diagnostic and prognostic values of Glypicans gene expression in patients with hepatocellular carcinoma
    Wang, Jian-Yao
    Wang, Xiang-Kun
    Zhu, Guang-Zhi
    Zhou, Xin
    Yao, Jun
    Ma, Xiao-Peng
    Wang, Bin
    Peng, Tao
    BMC CANCER, 2021, 21 (01)